These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23731945

  • 1. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K, Xue JY, Zhu HL.
    Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4235-8. PubMed ID: 23731945
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F, Wen Q, Wang SF, Shahla Karim B, Yang YS, Liu JJ, Zhang WM, Zhu HL.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):90-5. PubMed ID: 24332628
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL, Zhang YB, Tang JF, Yang YS, Chen RQ, Zhang F, Zhu HL.
    Eur J Med Chem; 2012 Nov 01; 57():373-82. PubMed ID: 23124163
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y, Zhao CP, Ma HP, Zhao MY, Xue YR, Wang XM, Zhu HL.
    Bioorg Med Chem; 2013 Jun 01; 21(11):3120-6. PubMed ID: 23602519
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL.
    Eur J Med Chem; 2010 Sep 01; 45(9):4358-64. PubMed ID: 20557983
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC, Wang KR, Yang Y, Mao WJ, Chen J, Xiong J, Zhu HL.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6750-4. PubMed ID: 19836235
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840
    [Abstract] [Full Text] [Related]

  • 8. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
    Lee JY, Jeong KW, Lee JU, Kang DI, Kim Y.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1506-13. PubMed ID: 19185501
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR, Li DD, Wang RR, Sun J, Dong JJ, Du QR, Fang F, Zhang WM, Zhu HL.
    Eur J Med Chem; 2014 Mar 21; 75():438-47. PubMed ID: 24561667
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Wu X, Qiao F, Sha S, Lv PC, Zhao J, Zhu HL.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5727-37. PubMed ID: 25306465
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y, Luo Y, Hu Y, Zhu DD, Zhang S, Liu ZJ, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4316-22. PubMed ID: 22710102
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
    Zhang HJ, Qin X, Liu K, Zhu DD, Wang XM, Zhu HL.
    Bioorg Med Chem; 2011 Sep 15; 19(18):5708-15. PubMed ID: 21872479
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.
    Cheng K, Zheng QZ, Qian Y, Shi L, Zhao J, Zhu HL.
    Bioorg Med Chem; 2009 Dec 01; 17(23):7861-71. PubMed ID: 19884012
    [Abstract] [Full Text] [Related]

  • 14. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
    Ahmad H, Ahmad F, Parveen S, Ahmad S, Azam SS, Hassan A.
    Bioorg Chem; 2020 Dec 01; 105():104426. PubMed ID: 33161255
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.
    Song X, Yang Y, Zhao J, Chen Y.
    Chem Pharm Bull (Tokyo); 2014 Dec 01; 62(11):1110-8. PubMed ID: 25196128
    [Abstract] [Full Text] [Related]

  • 16. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y, Du QR, Sun J, Li JR, Fang F, Li DD, Qian Y, Gong HB, Zhao J, Zhu HL.
    ChemMedChem; 2013 Mar 01; 8(3):433-41. PubMed ID: 23401291
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL, Li QS, Zhang HJ, Hu Y, Zhu DD, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4413-20. PubMed ID: 21752655
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
    Qin YJ, Wang PF, Makawana JA, Wang ZC, Wang ZN, Yan-Gu, Jiang AQ, Zhu HL.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5279-83. PubMed ID: 25587588
    [Abstract] [Full Text] [Related]

  • 19. Facile regioselective synthesis of novel bis-thiazole derivatives and their antimicrobial activity.
    Mahmoodi NO, Parvizi J, Sharifzadeh B, Rassa M.
    Arch Pharm (Weinheim); 2013 Dec 15; 346(12):860-4. PubMed ID: 24136795
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL.
    Bioorg Med Chem; 2009 Sep 01; 17(17):6264-9. PubMed ID: 19664929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.